Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Frydland

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 8, 2025
The prognostic value of neurohormonal and inflammatory biomarkers in addition to the TIMI risk score in patients with ST-elevation myocardial infarctionSarah Louise Duus Holle, Helle Søholm, Jacob Eifer Møller, et al.
Journal of the American Heart Association|May 20, 2018
MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) SubstudyAlexander C Falkentoft, Rasmus Rørth, Kasper Iversen, et al.
The American Journal of Cardiology|September 12, 2016
Usefulness of Serum B-Type Natriuretic Peptide Levels in Comatose Patients Resuscitated from Out-of-Hospital Cardiac Arrest to Predict OutcomeMartin Frydland, Jesper Kjaergaard, David Erlinge, et al.
European Heart Journal. Acute Cardiovascular Care|December 10, 2024
Lower vs. higher blood pressure targets during intensive care of comatose patients resuscitated from out-of-hospital cardiac arrest-a Bayesian analysis of the BOX trialJohannes Grand, Anders Granholm, Sebastian Wiberg, et al.
Resuscitation|December 16, 2023
Impact of blood pressure targets on central hemodynamics during intensive care after out-of-hospital cardiac arrestJohannes Grand, Jacob E Møller, Christian Hassager, et al.
Shock (Augusta, Ga.)|October 5, 2018
Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial InfarctionMartin Frydland, Jacob Eifer Møller, Sebastian Wiberg, et al.
JAMA Cardiology|August 30, 2025
Systolic Blood Pressure and Microaxial Flow Pump-Associated Survival in Infarct-Related Cardiogenic Shock: A Post Hoc Analysis of the DanGer Shock Randomized Clinical TrialAstrid Duus Mikkelsen, Rasmus Paulin Beske, Lisette Okkels Jensen, et al.
JAMA Cardiology|October 27, 2024
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock: A Substudy of the DanGer Shock Randomized Clinical TrialNanna Louise Junker Udesen, Rasmus Paulin Beske, Christian Hassager, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Bleeding in Patients With Infarct-Related Cardiogenic Shock: A DanGer Shock SubstudyRikke Sørensen, Jacob Eifer Møller, Christophe Vandenbriele, et al.
The New England Journal of Medicine|August 26, 2022
Blood-Pressure Targets in Comatose Survivors of Cardiac ArrestJesper Kjaergaard, Jacob E Møller, Henrik Schmidt, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 8, 2025
The prognostic value of neurohormonal and inflammatory biomarkers in addition to the TIMI risk score in patients with ST-elevation myocardial infarctionSarah Louise Duus Holle, Helle Søholm, Jacob Eifer Møller, et al.
Journal of the American Heart Association|May 20, 2018
MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) SubstudyAlexander C Falkentoft, Rasmus Rørth, Kasper Iversen, et al.
The American Journal of Cardiology|September 12, 2016
Usefulness of Serum B-Type Natriuretic Peptide Levels in Comatose Patients Resuscitated from Out-of-Hospital Cardiac Arrest to Predict OutcomeMartin Frydland, Jesper Kjaergaard, David Erlinge, et al.
European Heart Journal. Acute Cardiovascular Care|December 10, 2024
Lower vs. higher blood pressure targets during intensive care of comatose patients resuscitated from out-of-hospital cardiac arrest-a Bayesian analysis of the BOX trialJohannes Grand, Anders Granholm, Sebastian Wiberg, et al.
Resuscitation|December 16, 2023
Impact of blood pressure targets on central hemodynamics during intensive care after out-of-hospital cardiac arrestJohannes Grand, Jacob E Møller, Christian Hassager, et al.
Shock (Augusta, Ga.)|October 5, 2018
Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial InfarctionMartin Frydland, Jacob Eifer Møller, Sebastian Wiberg, et al.
JAMA Cardiology|August 30, 2025
Systolic Blood Pressure and Microaxial Flow Pump-Associated Survival in Infarct-Related Cardiogenic Shock: A Post Hoc Analysis of the DanGer Shock Randomized Clinical TrialAstrid Duus Mikkelsen, Rasmus Paulin Beske, Lisette Okkels Jensen, et al.
JAMA Cardiology|October 27, 2024
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock: A Substudy of the DanGer Shock Randomized Clinical TrialNanna Louise Junker Udesen, Rasmus Paulin Beske, Christian Hassager, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Bleeding in Patients With Infarct-Related Cardiogenic Shock: A DanGer Shock SubstudyRikke Sørensen, Jacob Eifer Møller, Christophe Vandenbriele, et al.
The New England Journal of Medicine|August 26, 2022
Blood-Pressure Targets in Comatose Survivors of Cardiac ArrestJesper Kjaergaard, Jacob E Møller, Henrik Schmidt, et al.
Pageof 7